This study aimed for assessment of antischistosomal properties of an antimalarial drug, mefl oquine (MFQ), on juvenile and adult Schistosoma haematobium worms.
Introduction
Human schistosomiasis is an important tropical disease, which is highly prevalent worldwide [1, 2] . Th e disease is associated with pathologies that infl ict a burden of up to 70 million disability adjusted life years lost annually [3] . Treatment and control of schistosomiasis rely almost exclusively on praziquantel (PZQ) [4, 5] . However, drug resistance is a distinguished threat, which is further worsened by the large-scale administration of PZQ [6, 7] . It is a well-established fact that PZQ is eff ective against adult schistosomes and very early stages of schistosomula a few hours after penetrating into host's skin; however, an important fault of PZQ is its much less effi cacy against young developing stages of schistosomula [5, 8, 9] . Th is might impact on the cure rate of the patients treated with PZQ or reinfection of individuals after treatment with PZQ in areas of heavy schistosomiasis transmission [10] [11] [12] [13] . Metrifonate, another antischistosomal drug eff ective mainly against Schistosoma haematobium, however, requires multiple administrations and is therefore operationally less convenient in community-based control programs [14] . Hence, there is need for discovery and development research that might eventually deliver new antischistosomal drugs [7, 15, 16] . New research has shown that the antimalarial drug mefl oquine (MFQ), an arylaminoalcohol, exhibits antischistosomal properties [2, 17] . Th is was reported for Schistosoma mansoni [2, 18] , Schistosoma japonicum [19] [20] [21] [22] , and S. haematobium infection of pregnant women [23] . Selem and Eraky [24] attempted to evaluate MFQ schistosomicidal properties on S. haematobium immature stage. Following in vitro incubation, they found the drug to be highly eff ective, reporting extensive tegumental damage of the immature stage, which intensifi ed progressively as the incubation period and the MFQ concentration increased. Only one experimental in vivo study was reported for adult S. haematobium [25] in which worms were treated 90 days postinfection (PI) with single oral doses of 100 and Assessment of mefl oquine in-vivo effi cacy on juvenile and adult stages of Schistosoma haematobium (Egyptian strain) Rabab 
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Background
The large-scale use of praziquantel might result in selection of drug-resistant parasites. Hence, there is an important need to develop new antischistosomal compounds.
200 mg/kg MFQ. Th e antischistosomal eff ect evaluated 14 days post-treatment reported good MFQ activity with worm burden reductions of 61.9 and 93.7% observed at dosages of 100 and 200 mg/kg, respectively. However, until now, there are no data available in the literature regarding the in vivo experimental assessment of MFQ antischistosomal properties against the Egyptian strain of S. haematobium parasite. Th is prompted us to evaluate MFQ effi cacy against both juvenile and adult stages of this strain of S. haematobium infection in hamsters through a controlled experimental study.
Materials and methods
Th e present study was carried out at Schistosome Biological Supply Center (SBSC), Th eodor Bilharz Research Institute (TBRI), Giza, Egypt during the period from December 2012 to March 2013.
Animals
A batch of male Syrian hamsters (Mesocricetus auratus), 100-120 g each, were purchased from SBSC. Th e animals were kept under environmentally controlled conditions (temperature: 25°C; humidity: 70%; 12-h light and 12-h dark cycle) and acclimatized for 1 week before infection. Th e animals had free access to water and rodent diet, composed of standard pellet diet containing 24% protein, 4% fat, and about 4-5% fi ber and water ad libitum. At treatment, the animals were grouped according to the number of survivors.
Parasite
Cercariae of S. haematobium (Egyptian strain), shed from infected Bulinus truncatus snails [26] that are reared at SBSC, were used within 1 h from shedding to infect the hamsters.
Drug
Imported MFQ tablets (250 mg) (F. Hoff mann-La Roche Ltd, Basel, Switzerland) were purchased locally. Th e active ingredient mefl oquine hydrochloride-8-racemate was weighed to determine its percentile weight and suspended in 7% (v/v) Tween 80 and 3% ethanol with a fi nal concentration of 40 mg/ml. MFQ was administered orally as a freshly prepared suspension, using a ball-tipped feeding needle, at a single dose of 200 mg/kg (each animal receive 0.5 ml equivalent to the dose of 200 mg/kg) [25] .
Study design
Animals were randomly divided into two main groups according to time of drug administration. Group I (juvenile or prepatent or preadult immature infection) was subdivided into two subgroups:
(a) Received MFQ 49 days PI and (b) Represented the corresponding untreated control.
Group II (adult or patent mature infection) was subdivided into two subgroups:
(a) Received MFQ 82 days PI and (b) Represented the corresponding untreated control.
Ten days post-treatment, animals of all groups were killed and dissected as described by Duvall and Dewitt [27] to evaluate the possible eff ect of MFQ.
Animal infection
Each hamster received 400 cercariae through abdominal skin exposure. Th e maintenance and care of animals during experimentation was compliant with the international guidelines for the human use of laboratory animals.
Evaluation of the therapeutic effect of mefl oquine
For the determination of worm burden, animals were perfused using Master Flex Pump according to Duvall and Dewitt [27] . Worms obtained from hepatic and portomesentric veins of infected untreated and treated animals were sexed and counted as described by Xiao et al. [28] . Drug effi cacy was calculated as percent reduction of worms according to the following formula [29] : R% (percent reduction) = C-T/C ×100, where C is the mean worm burdens in control infected animals and T, mean number of worms in infected treated animals.
Determination of egg load in the adult infection group
Portions of liver and intestine segments were blotted between two fi lter papers, weighed, transferred each to a test tube containing 5 ml 5% potassium hydroxide solution [30] , and left overnight at room temperature to facilitate tissue digestion without egg destruction. Next morning, tubes were incubated at 37°C for 1 h to complete tissue clearance [31] . Ova in homogenous emulsions were counted after being spread on slides, and the number of ova/mg tissues was calculated. Th e hepatic and intestinal tissue egg loads were determined by multiplying the average number of eggs in 1 ml sample by the total volume of potassium hydroxide, then dividing by weight of tissue to yield the number of eggs/gram tissue [32] . Percentage reduction was accordingly calculated. R% (percent reduction) = C-T/C ×100, where C is the mean number of ova in infected untreated animal control and T, mean number of ova in infected treated animal [29] .
Oogram pattern in the infected adult group
After perfusion, the small intestine was separated and transferred to a Petri dish. Th ree fragments (each 1 cm in length) of the small intestine were cut longitudinally, rinsed in saline, slightly dried on a fi lter paper, and then placed between a slide and cover slip. Th e fragments were examined by low-power microscopy; the stage of each egg was recorded; and then the mean number of various stages was calculated for each animal. A total of 100 eggs were examined microscopically and classifi ed into immature (containing immature miracidium), mature (containing mature miracidium), and dead eggs in the infected untreated controls, whereas in infected treated hamsters, as the number of eggs may be reduced, the percentages were computed from the total number of eggs seen [33] . It was important to carry out the oogram on the same day of killing animals. If for any reason this could not be performed, intestinal segments were immersed in normal saline and stored in refrigerator but not for more than 24 h [33] . Evaluation of schistosomal elements in the intestinal walls included viable and dead eggs. Viable eggs were either mature (having a fully developed miracidium) or immature showing a developing embryo. Dead eggs appeared granular, dark, semitransparent, or calcifi ed [33] .
Histopathological study
Livers of experimental hamsters were fi xed in neutral buff ered 10% formalin for subsequent preparation of hematoxylin and eosin-stained [34] and Masson trichrome-stained sections [35] . Examination was carried out per 10 adjacent fi elds under a light microscope to elucidate hepatic infl ammation, granuloma numbers, diameter of each single granuloma (containing only one Schistosoma spp. egg in its center), and total area of granulomas in square microns (μm 2 ). Morphometric analysis was carried out by means of Olympus soft imaging system, analysis life science program. Th e diameter of each granuloma containing a single ovum [36] was obtained by measuring two diameters of the lesion at right angles to each other. Th irty granulomas were measured per mouse. Th is was performed for each treated hamster individually, calculated for the whole group then compared with data of the corresponding control group.
Scanning electron microscopy study
Perfused hepatic and portomesentric S. haematobium worms were collected in glutaraldehyde buff er solution (25%) as a fi xative and left overnight at 4°C. Worms were washed off from traces of fi xative by keeping them overnight at 4°C in phosphate buff er, and then they were passed in increasing concentrations of alcohol (30, 40 , and 50%) each for 15 min. Worms were left in 70% alcohol until examined. Before examination, they were washed twice for 30 min in 80 and 90% alcohol, respectively. Th e last wash was for 1 h in 100% alcohol, after which worms were mounted on stainless steel holders, placed in a drier for about 30 min, and then subjected to a sputter coat of gold. Diff erent parts of worms were examined using Joel JEM-1200 scanning electron microscope, fi tted with a camera. Areas in the worms that showed specifi c changes were examined and photographed, mainly suckers and tubercles on the tegument [37] .
Statistical analysis
Data were evaluated as mean ± SEM. Th e means of various groups were compared using the Student t-test for parametric data and the Mann-Whitney U-test for nonparametric ones. P values were considered signifi cant at less than 0.05.
Ethical consideration
Th e animal experiments were carried out according to the internationally valid guidelines in an institution responsible for animal ethics (Th eodor Bilharz Research Institute, Embaba, Egypt).
Results
Worm burden
A single oral MFQ dose (200 mg/kg) given to S. haematobium-infected hamsters showed a more eff ective reduction of total worm burden in juvenile infection (Table 1 ) than in mature infection ( Table 2) . In juvenile infection, the reduction rate of the worm burden was signifi cant for male and coupled worms (75.9 and 88.6%, respectively), whereas reduction rate for female worms (69.6%) was insignifi cant. In mature infection, male worm burden was insignifi cantly reduced (24.8%), and the reduction rate was signifi cant with respect to coupled worms (95%). Th e mean number of female worms was 0.8 ± 0.4 as compared with 0.0 in controls.
Tissue egg load
Th e eff ect of MFQ treatment 82 days after cercarial infection on S. haematobium female fecundity in group IIa hamsters was assessed by comparing the egg load of a standard weight of both liver and intestine specimens with the corresponding control group. Th is revealed an insignifi cant egg load reduction rate in the liver (41.6%) and intestine (29%). Th e mean tissue egg load was insignifi cantly lower in treated animals as compared with their corresponding controls: 1414.8 ± 658.6 and 2671.4 ± 997, respectively, for liver and intestine specimens in treated animals and 2421 ± 1367.8 and 3765 ± 1506.6 in nontreated ones, respectively (P = 0.48 and 0.55, respectively) ( Table 3) .
Oogram pattern changes
In group IIa, the oogram pattern in the wall of the intestine showed partial decrease of immature eggs (42.2% reduction rate). Th e mean egg count (30.8 ± 7.8) was insignifi cantly lower than in control animals (53.3 ± 0.9) (P = 0.073). Th e mean mature egg count in treated animals was insignifi cantly higher than in control animals (40.6 ± 10.2 and 36.7 ± 0.9, respectively; P = 0.8). Comparison of dead egg count between treated and nontreated controls revealed an insignifi cant lower count in treated animals than in controls (8.4 ± 2.2 and 10 ± 1.2, respectively; P = 0.6) ( Table 4) .
Histopathological assessment
Th e histological sections of livers from group Ib control animals (49 days PI) demonstrated dilated congested sinusoids and central veins; hepatocytes showed hydropic degeneration with dense lymphocytic infi ltration of the portal tracts and necroinfl ammatory foci. In group Ia treated animals (49 days PI), sections showed dilated congested sinusoids; hepatocytes showed cloudy swelling and presence of some worms in liver veins and parenchyma surrounded by chronic infl ammatory cells, histocytes, and lymphocytes ( Fig. 1a and b) . In group IIa liver sections (treated 82 days PI), traditional cellular and fi brocellular schistosomal granulomas were detected. Well-formed cellular granulomas were present in hepatic parenchyma and portal tracts; the cells were mainly eosinophils, lymphocytes, plasma cells, epithelioid cells, few neutrophils, and fi broblasts. Eosinophils were present nearest the ova; lymphocytes and epithelioid cells were present at the center, whereas plasma cells and fi broblasts were predominantly present at the periphery. In fi brocellular granulomas, predominance of fi brous components was observed. Cells were mainly monocytes, plasma cells, and fi brocytes with fewer lymphocytes at the outer zone of the granulomas. Granulomas were clearly delineated from the surrounding liver tissue by delicate concentrically arranged collagenous fi brous tissue at the periphery of the granulomas. In both groups infected nontreated and treated animals, the two types of mentioned granulomas were detected in liver sections. However, in nontreated controls, the numbers of cellular granulomas were more than fi brocellular ones, and fi brocellular granulomas predominated in the treated animals group (Fig. 1c and d) .
With respect to the morphometric study of total (single+confl uent), single, and confl uent granulomas, in the control group IIa, the mean numbers were 7.6 ± 2.3, 5.4 ± 2.2, and 2.2 ± 0.86, respectively. In treated group IIa, the corresponding values were 8.7 ± 0.88, 4 ± 1.2, and 4.7 ± 1.9, respectively. Th ere was insignifi cant decrease of mean total, single, and confl uent granuloma numbers in treated animals as compared with the corresponding control data (P>0.05, Mann-Whitney U-test = 7.5, 7, and 3.5, respectively). Th e mean single granuloma diameter in control animals was 284.4 ± 70.8; after MFQ treatment, it was insignifi cantly decreased to 188.9 ± 52.5 (P>0.05, Mann-Whitney U-test = 4). Th e mean total granuloma area in control animals was 646247.1 ± 5.7, which also after MFQ treatment became insignifi cantly decreased to 84612.7 ± 46804.3 (P>0.05, Mann-Whitney U-test = 5) ( Table 5 ). Figure 1c and d illustrate the histopathological eff ect of MFQ in group IIa animals.
Scanning electron microscopy
Tegumental alterations observed on immature schistosomes in group Ia hamsters are presented in Fig. 2b-d , illustrating worm deformity and fl attened shrunken suckers. Tegument was swollen in some parts and fl attened in other parts with loss of the tubercles, shrinking, and furrowing. Schistosomes extracted from control infected animals showed an intact tegument (Fig. 1a) . MFQ eff ect on schistosomes tegument was more prominent in treated adults than in juvenile worms ( Fig. 3b-d) as compared with worms extracted from control untreated animals (Fig. 3a) .
Discussion
Schistosomiasis not only gives rise to a complex chronic and debilitating disease, but also results in acute manifestations caused by the host's vigorous immunological reactions to parasite eggs trapped in mesenteric veins, or lodged in particular organs, such as the liver [38, 39] . Th e antimalarial MFQ, a synthetic analog of quinine, has recently been shown to exhibit schistosomicidal activity against S. mansoni [2, 17, 40, 41] and S. japonicam [19] [20] [21] 42 ] in mice. However, minimal data exist in the literature about its effi cacy on S. haematobium except for one clinical trial that assessed the effi cacy and safety of MFQ (25 mg/kg) and artesunate (three doses of 4 mg/kg) and reported signifi cantly lower egg reduction rates with artesunatetreated (85%) and MFQ-treated children (74%) [43] . In another experiment on antischistosomal activities of MFQ-related arylmethanols [25] , worms were treated 90 days PI with a single oral dose of 100 and 200 mg/ kg MFQ. Animals were killed 14 days post-treatment and the antischistosomal eff ect was evaluated. Th e researchers found that MFQ showed good activity against S. haematobium in vivo with worm burden reductions of 61.9 and 93.7% observed at dosages of 100 and 200 mg/kg, respectively. In a previous study, evaluation of the in vivo eff ect of single oral dose of MFQ 200 mg/kg on diff erent stages of S. mansoni found it to be highly eff ective against all stages especially immature stages than chronic and mature stages [18] . In addition, the evaluation of the in vitro eff ect of MFQ on S. haematobium immature and mature stages found MFQ highly eff ective [24] . Hence, we endeavored to explore MFQ antischistosomal eff ect regarding the Egyptian strain of S. haematobium by an in vivo controlled experimental study. regimen as increasing the dose or adding another dose after a suitable interval.
Th e histopathological changes infl icted by MFQ on adult stages of S. haematobium infection revealed its considerable therapeutic eff ect. Although the mean total number of hepatic granulomas did not diff er greatly in treated animals, there was an obvious leaning toward formation of single granulomas in the general build up of treated cases. Conversely, the mean of confl uent ones declined up to half in control animals, which indicates that MFQ has a reasonable eff ect on the immune mechanisms concerned with granuloma formation and evolution. Th is however remains to be more elucidated in further studies.
In the same context, MFQ treatment resulted in an insignifi cant decrease of mean granuloma diameter to about two-third of control animals. Moreover, the mean granuloma area in livers of treated animals was markedly decreased to about one-tenth of control nontreated animals. However, considering the high SEM that came to light during statistical analysis, this decrease could not be considered signifi cant. Th ese histopathological results tuned with the parasitological results (egg count and oogram pattern) in view of sharing the observable but nonsignifi cant aff ect of MFQ treatment, which is easily explained by the fact that Schistosoma spp. granuloma is mostly induced by an antiegg immunopathological reaction [38] . Nevertheless, the overall histopathological eff ect of MFQ treatment is encouraging and incentive for more wide-scaled trials.
Regarding scanning electron microscopy studies, tegumental alterations observed were more or less similar to those reported by other authors [2, 40] . Th e evidently more pronounced shrinking, scattered blebbing, swelling, and furrowing of immature stage teguments are in harmony with other recorded parasitological parameters that indicated higher MFQ eff ect on immature parasites and promising effi cacy on mature ones.
Conclusion
Th e use of the marketed drug MFQ as coadjuvant treatment with PZQ in human S. haematobium suggests that it may be an instrumental promising antischistosomal drug. It appears to be useful for decreasing disease morbidity and could effi ciently contribute to community control programs through its pronouncing therapeutic eff ect on immature parasite stages, hence aborting inf ection and minimizing egg laying, which is the trigger action in disease cascade of immunopathological events. It is also important to consider treatment with MFQ as a compensation for PZQ-known defective effi cacy against the immature parasite stages. Further laboratory and clinical studies are warranted to unravel the eff ect of MFQ on human S. haematobium and deduce the suitable dosage regimen on a sound cost-benefi t rat io vision.
